On July 1, 2019, Mr. Wesley D. Tate announced the Board of Directors of Cerebain Biotech Corp., that he was resigning as the Company's Chief Financial Officer, Chief Operating Officer and as a member of its Board of Directors, effective July 15, 2019. Mr. Tate's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Cerebain Biotech Corp.
Equities
CBBT
US15672M1062
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |